140 participants
Donanemab (LY3002813) Trial in Chinese Participants With Cognitively Unimpaired (Preclinical) Alzheimer's Disease
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-24
- Start Date:
- 2026-04-30
- Completion:
- 2030-04-30
Conditions
- Alzheimer Disease
Interventions
- DRUG
No Results Yet